Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.08.2005 The Group achieved the following results in the first six months: 2005 (6 mon.) 2004 (6 mon.) Change Turnover K EUR 15,787 11,159 + ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.07.2005 curasan AG - specialists in regenerative medicine - today received 510(k) approval by the FDA for Cerasorb® M Dental and Cerasorb® Perio. Cerasorb® is a synthetic bone ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.05.2005 The group generated the following results in the first three months: ~ 2005 (3 mon.) 2004 (3 mon.) Change Turnover ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Altered market conditions have induced K+S Group to modify the US-Dollar hedging based on range options. All outstanding options for the years 2005, 2006 and 2007 now carry upper knock-outs of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Second quarter revenues rose by 19% to EUR 626.4 million. In addition to business developing favourably, especially in the case of potash and magnesium products, the first-time consolidation of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In 2003, revenues increased by 1.3% to EUR 2,287.8 million. EBIT totalled EUR 115.7 million (-12.9%). At EUR 101.3 million, net income almost matched the figure of a year ago (-2.4%). Earnings ...
